Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2021-01-06 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities. It includes confirmations related to securities issuance and compliance with listing rules. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. This type of document is a regulatory filing reporting share capital movements and confirmations to the stock exchange, fitting the category of Regulatory Filings (RNS). It is not an announcement of a report, nor a full financial report or earnings release, but a compliance and disclosure document related to share capital changes.
2021-01-06 English
Monthly Returns
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities issued during the month, including share options and warrants, with no financial performance data or earnings information. This type of document is a regulatory filing reporting share capital movements and is not a full financial report, earnings release, or management discussion. It fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-01-04 English
INSIDE INFORMATION-DEBT FINANCING TRANSACTION OF AN OVERSEAS SUBSIDIARY RECONSOLIDATION OF WATAGAN
Capital/Financing Update Classification · 95% confidence The document is an announcement by Yanzhou Coal Mining Company Limited regarding the debt financing transaction and re-consolidation of an overseas subsidiary, Watagan. It references specific financial arrangements, bond issues, refinancing agreements, and the impact on the company's financial results. The document is structured as a formal announcement under the Hong Kong Listing Rules, disclosing inside information about financing and corporate structure changes. It does not contain full financial statements or detailed financial performance data typical of an Annual Report (10-K) or Interim Report (IR). Instead, it focuses on financing transactions and corporate restructuring related to debt and subsidiary consolidation. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (8331 characters) and content support this classification with high confidence.
2020-12-16 English
CLOSING COMPLETION OF MAJOR AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE TARGET EQUITY INTERESTS AND TARGET ASSETS
M&A Activity Classification · 95% confidence The document is an announcement from Yanzhou Coal Mining Company Limited regarding the closing completion of a major and connected transaction related to the acquisition of target equity interests and assets. It references previous announcements and a circular related to the transaction, confirms the closing date, and mentions subsequent handling per the transaction agreement. The document is relatively short (2481 characters) and serves as an update on the transaction completion rather than a detailed report or audit. It does not contain full financial statements or detailed financial analysis, nor is it a proxy, voting result, or management change announcement. The content fits best with a Major Shareholding Notification or M&A Activity, but since it specifically relates to the completion of a major transaction and acquisition, the appropriate classification is M&A Activity (TAR).
2020-12-15 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCED U.S. FDA HAS APPROVED GAVRETO (PRALSETINIB) FOR THE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC RET-MUTANT AND RET FU
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals regarding the FDA approval of a drug (GAVRETO™) developed by its partner Blueprint Medicines. It contains no financial data, no detailed financial statements, no management discussion of financial results, and no regulatory certifications. It is a corporate announcement about a product approval and partnership update. The document is relatively short (5563 characters) and does not present itself as a report or filing of financial or governance nature. It is not an earnings release, annual report, or any form of regulatory filing. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories.
2020-12-10 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTION PASSED AT THE 2020 SECOND EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement regarding the resolutions passed at the 2020 Second Extraordinary General Meeting (EGM) of Yanzhou Coal Mining Company Limited. It details the convening and attendance of the EGM, voting results on various resolutions, compliance with relevant laws and regulations, presence of scrutineers and lawyers, and legal opinions confirming the validity of the meeting and voting procedures. The content focuses on the official results of shareholder votes at a general meeting, including detailed voting statistics and resolutions passed. There is no indication that this is a full annual report, audit report, or other financial report. The document is not a proxy solicitation or a presentation but an official announcement of voting results from a shareholder meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support a high confidence in this classification.
2020-12-09 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.